L.COMTE ARASSUS – Brenus Pharma

Laurence Comte Arassus is an experienced business leader with a proven track record of success in the healthcare and medical device industries.

She currently serves as General Manager of GE Healthcare (FBFA zone) and Administrator of IHU Ican, Vice President of SNITEM, and Board Member of GS1 France.

She is also the former President of Medtronic France . Laurence is a strategic thinker with a strong focus on innovation and customer satisfaction.

Laurence is a role model for aspiring women in the industry, demonstrating her unwavering commitment to promoting gender diversity and equality in the field.

INCREASE IMMUNOGENICITY

Brenus’ manufacturing process overpasses the lack of immunogenicity & educates the immune system with visible and multi-specific targets

REPRESENT HETEROGENEITY OF THE TARGETED INDICATION

Selection criteria of starting material (Allogeneic tumor cell lines)

Representative oncogenic drivers (TP53,BRAF,KRAS,…)
Cold & hot tumor cell lines
Resistances capacities (metabolic ; chemical & physical)

Increase antigenicity

Brenus’ manufacturing process overpasses the lack of antigenicity & educates the immune system with a broad & higher quality range of tumor antigens